WASHINGTON, Oct. 31, 2016 /PRNewswire/ — Danaher Corporation (NYSE:DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Baird 2016 Global Industrial Conference in Chicago, Illinois on Wednesday, November 9, 2016 at 8:00 a.m. CT. The audio will be simultaneously webcast and the presentation will be archived on... Read more
–Patent No. 1802752 “Parellel Patch Clamp System” Upheld in European Patent Office- Sunnyvale, California – October 7, 2016. Molecular Devices, LLC, a company committed to providing innovative analytical solutions for protein and cell biology, announced today that its European Patent No. 1802752 titled “Parallel Patch Clamp System” was upheld by the European Patent Office in... Read more
Molecular Devices, a leader in bioanalytical systems for drug discovery, life science research, and bioassay development, today announced the launch of the SpectraMax® QuickDrop™ Micro-Volume Spectrophotometer. The QuickDrop Spectrophotometer addresses the needs of life science researchers who quantify very small amounts of DNA, RNA, oligos, and proteins. The QuickDrop Spectrophotometer provides researchers with the flexibility... Read more
A new type of fluorescent bead is presented by GATTAquant. These beads, called GATTA-Beads, are characterized by a small diameter (23 nm), high intensity and size uniformity. In combination with state-of the-art STED microscopes such as the Leica TCS SP8 STED 3X and high-end image restoration methods available in the Huygens Software, it is shown... Read more
WASHINGTON, Sept. 8, 2016 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Daniel L. Comas, will be presenting at the Morgan Stanley Laguna Conference in Dana Point, California on Thursday, September 15, 2016 at 9:20 a.m. PT. The audio will be simultaneously webcast and the presentation will be archived... Read more
WASHINGTON, Sept. 6, 2016 /PRNewswire/ — Danaher Corporation (NYSE:DHR) (“Danaher” or the “Company”) announced today that it has entered into a definitive merger agreement with Cepheid (NASDAQ:CPHD) pursuant to which Danaher will acquire all of the outstanding shares of Cepheid for $53.00 per share in cash, or a total enterprise value of approximately $4 billion... Read more
WASHINGTON, Aug. 23, 2016 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Daniel L. Comas, will be presenting at the Vertical Research Partners Industrial Conference in Westbrook, Connecticut on Wednesday, September 7, 2016 at 10:15 a.m. ET. About Danaher Danaher is a global science and technology innovator committed to... Read more
NanoRacks, LLC is installing a new, reconfigured Molecular Devices’ SpectraMax M5e multi-mode microplate reader on the International Space Station to perform experiments in microgravity. SUNNYVALE, CALIF. — JULY 19, 2016 Molecular Devices, LLC, a leader in protein and cell biology technologies, today announced the launch of the SpectraMax M5e Multi-Mode Microplate Reader to the International Space... Read more
Beckman Coulter Diagnostics to Place Ortho’s VITROS® 3600 Systems in Very High-Volume Labs; Expands Reach for Ortho and Broadens Menu for Beckman Coulter BREA, CA, and RARITAN, NJ, June 8, 2016 — Beckman Coulter, Inc., a global developer and manufacturer of clinical diagnostic products, and Ortho Clinical Diagnostics (Ortho), a global in vitro diagnostics... Read more
XP Media and CloneMedia enable researchers to get to high-value clones faster with a complete hybridoma media solution for cell line development Sunnyvale, Calif. – May 24, 2016 – Molecular Devices, LLC, a leader in protein and cell biology technologies, today announced the launch of XP Media and CloneMedia for mouse hybridoma generation, a complete solution that... Read more